Haloperidol-induced neuronal apoptosis: Role of p38 and c-Jun-NH2-terminal protein kinase

Journal of Neurochemistry

Volumn 75, Issue 6, 2000, Pages 2327-2334

  Jai Sung Noh, ^a   Hyo Jung Kang, ^a   Eun Young Kim, ^a   Sohn, S ^a   Young Ki Chung, ^a   Kim, S U ^a   Gwag, B J ^a  

^a Ajou University School of Medicine   (South Korea)

Author keywords

Apoptosis; C Jun NH2 terminal protein kinase; Cycloheximide; Haloperidol; Insulin; P38

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 NITROPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; CYCLOHEXIMIDE; HALOPERIDOL; INSULIN; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE INHIBITOR; PROTEIN SYNTHESIS INHIBITOR; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL AGGREGATION; CHROMATIN CONDENSATION; CONTROLLED STUDY; DNA DEGRADATION; DRUG ANTAGONISM; ENZYME ACTIVATION; ENZYME ACTIVITY; FETUS; MOUSE; NERVE CELL DEGENERATION; NERVE CELL NECROSIS; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; CELLS, CULTURED; CYCLOHEXIMIDE; DNA FRAGMENTATION; ENZYME INHIBITORS; EXCITATORY AMINO ACID ANTAGONISTS; FREE RADICALS; HALOPERIDOL; IMIDAZOLES; INSULIN; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MICE; MITOGEN-ACTIVATED PROTEIN KINASES; NEURONS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN SYNTHESIS INHIBITORS;

ANIMALIA;

EID: 0033773187     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2000.0752327.x     Document Type: Article

References (41)

1. Haloperidol-induced cell death - Mechanism and protection with vitamin E in vitro
2. The activation of p38 and apoptosis by the inhibition of Erk is antagonized by the phosphoinositide 3-kinase/Akt pathway
3. The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and gamma radiation. Duration of JNK activation may determine cell death and proliferation
4. Neuropathological investigation of 28 brains from patients with dyskinesia
5. Striatal dopamine receptors become supersensitive while rats are given trifluoperazine for six months
6. Basal ganglia abnormalities in tardive dyskinesia. Possible relationship with duration of neuroleptic treatment
7. Drug-induced movement disorders
8. Role of the Jun kinase pathway in the regulation of c-Jun expression and apoptosis in sympathetic neurons
9. Peroxynitrite-induced cytotoxicity in PC12 cells: Evidence for an apoptotic mechanism differentially modulated by neurotrophic factors
10. Chronic blockade of dopamine receptors by antischizophrenic drugs enhances GABA binding in substantia nigra
11. The treatment of tardive dyskinesia with baclofen
12. Inhibition of protein phosphatase-2B (calcineurin) activity towards Alzheimer abnormally phosphorylated tau by neuroleptics
13. Association with persistent neuroleptic-induced dyskinesia of regional changes in brain GABA synthesis
14. Slowly triggered excitotoxicity occurs by necrosis in cortical cultures
15. Execution of ASK1-induced apoptosis by the mitochondria-dependent caspase activation
16. Apoptosis signaling pathway in T cells is composed of ICE/Ced-3 family proteases and MAP kinase kinase 6b
17. Induction of apoptosis by ASK1, a mammalian MAPKKK that activates SAPK/JNK and p38 signaling pathways
18. Study of neuropathologic changes in the striatum following 4, 8 and 12 months of treatment with fluphenazine in rats
19. Signal transduction pathways regulated by mitogen-activated/extracellular response kinase kinase kinase induce cell death
20. Suppression of interleukin-1 beta-converting enzyme-mediated cell death by insulin-like growth factor
21. The effect of tetrahydroisoxazolopyridinol (THIP) in tardive dyskinesia: A new gamma-aminobutyric acid agonist
22. Apoptosis induced by withdrawal of trophic factors is mediated by p38 mitogen-activated protein kinase
23. Bcl-2 prevents hippocampal cell death induced by the neuroleptic drug haloperidol
24. Biochemical characterization of programmed cell death in NGF-deprived sympathetic neurons
25. Cyclosporine induces neuronal apoptosis and selective oligodendrocyte death in cortical cultures
26. MRI abnormalities in tardive dyskinesia
27. Evidence for cell loss in corpus striatum after long-term treatment with a neuroleptic drug (flupenithixol) in rats
28. Attenuation of oxidative neuronal necrosis by a dopamine D1 agonist in mouse cortical cell cultures
29. Haloperidol-induced neuronal apoptosis: Blockade by neurotrophins and IGFs
30. Induction of NF-kappaB activity during haloperidol-induced oxidative toxicity in clonal hippocampal cells: Suppression of NF-kappaB and neuroprotection by antioxidants
31. Phosphatidylinositol 3-kinase-mediated regulation of neuronal apoptosis and necrosis by insulin and IGF-I
32. Induction of reactive oxygen species in neurons by haloperidol
33. Neuroprotective effect of high glucose against NMDA, free radical, and oxygenglucose deprivation through enhanced mitochondrial potentials
34. Role of TAKI and TABI in BMP signaling in early Xenopus development
35. Trichothecene mycotoxins trigger a ribotoxic stress response that activates c-Jun N-terminal kinase and p38 mitogen-activated protein kinase and induces apoptosis
36. Inhibition of phosphatidylinositol 3-kinase activity elevates c-Jun N-terminal kinase activity in apoptosis of cultured cerebellar granule neurons
37. Glutamate neurotoxicity in mouse cortical neurons: Atypical necrosis with DNA ladders and chromatin condensation
38. Blood to brain distribution of neuroleptics
39. Requirement for ceramideinitiated SAPK/JNK signalling in stress-induced apoptosis
40. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis
41. p38 mitogen-activated protein kinase mediates Bid cleavage, mitochondrial dysfunction, and caspase-3 activation during apoptosis induced by singlet oxygen, but not by hydrogen peroxide